Global Infant Phototherapy Devices Market Size By Type (Fluorescent Lamps (FL), Light-emitting Diodes (LEDs)), By Application (Hospital, Neonatal Clinics), By Region, And Segment Forecasts, 2023 to 20...

The Global Infant Phototherapy Devices Market was valued at USD 432 million in 2023 and is projected to reach USD 739 million by 2031, growing at a CAGR of 6.7% during the forecast period from 2023 to 2031. The market is experiencing robust growth due to the rising incidence of neonatal jaundice, increasing awareness regarding infant health, and the growing availability of advanced phototherapy equipment. Infant phototherapy devices, such as LED and fiber optic systems, are essential in managing hyperbilirubinemia in newborns, a condition that can lead to severe complications if untreated. Technological advancements, coupled with expanding healthcare infrastructure in emerging economies, are further bolstering market demand.

Drivers:

1. Rising Prevalence of Neonatal Jaundice:

More than 60% of newborns globally experience some degree of jaundice, making phototherapy a critical treatment. This rising prevalence is a major driver for the infant phototherapy devices market.

2. Technological Advancements in Phototherapy:

The development of compact, portable, and efficient LED-based phototherapy units is enhancing treatment outcomes and driving adoption in both hospitals and homecare settings.

3. Improved Access to Neonatal Care:

Expanding healthcare infrastructure, particularly in Asia-Pacific and Africa, is improving access to neonatal care services, increasing the use of phototherapy devices in both public and private health facilities.

Restraints:

1. High Cost of Advanced Devices:

While newer LED-based systems offer higher efficacy, their higher upfront costs can limit adoption in low-resource settings, especially in rural hospitals and clinics.

2. Lack of Trained Healthcare Personnel:

In many developing countries, the shortage of trained neonatologists and nurses can hamper the effective utilization of phototherapy devices, affecting treatment quality and market penetration.

Opportunity:

1. Home-Based Phototherapy Solutions:

The increasing demand for homecare treatment options, particularly in urban settings, is driving innovations in portable phototherapy devices, offering lucrative growth opportunities.

2. Expansion in Emerging Markets:

Rising healthcare investments and improving neonatal care awareness in regions like Southeast Asia, Latin America, and Sub-Saharan Africa create favorable conditions for market expansion.

Market by System Type Insights:

The LED Phototherapy Devices segment dominated the market in 2023 and is expected to maintain its lead throughout the forecast period. LEDs are preferred due to their energy efficiency, low heat production, and higher intensity of therapeutic light. Additionally, Fiber Optic Phototherapy Devices are gaining traction due to their suitability for home-based care and improved infant comfort.

Market by End-use Insights:

The Hospitals & Clinics segment accounted for the largest share in 2023, driven by the high volume of births and the need for professional medical supervision in the treatment of neonatal jaundice. However, the Homecare Settings segment is projected to grow at the highest CAGR due to increased awareness, improved accessibility to portable devices, and rising preference for at-home neonatal care.

Market by Regional Insights:

North America held the largest market share in 2023, supported by well-established healthcare systems, high awareness levels, and favorable reimbursement policies. Meanwhile, Asia-Pacific is anticipated to register the fastest growth, driven by large birth rates, increasing investments in neonatal care, and government-led health initiatives in countries such as India and China.

Competitive Scenario:

Key players in the global infant phototherapy devices market include GE Healthcare, Natus Medical Incorporated, Philips Healthcare, Drägerwerk AG & Co. KGaA, Atom Medical Corporation, Phoenix Medical Systems Pvt. Ltd., Ningbo David Medical Device Co. Ltd., and Alfamedic s.r.o. These companies are focusing on product innovations, strategic collaborations, and geographical expansion to strengthen their market footprint.

Key Market Developments:

2023: GE Healthcare launched a new portable LED phototherapy system optimized for use in rural clinics and homecare settings.

2024: Philips Healthcare introduced an AI-integrated neonatal monitoring solution combined with phototherapy functionalities to improve patient outcomes.

2025: Natus Medical announced a strategic partnership with a regional health network in Latin America to deploy phototherapy devices in underserved communities.

Scope of Work – Global Infant Phototherapy Devices Market

Report Metric Details

Market Size (2023) USD 432 million

Projected Market Size (2031) USD 739 million

CAGR (2023–2031) 6.7%

Market Segments System Type (LED, Fiber Optic), End-Use (Hospitals, Homecare), Region

Growth Drivers Rising prevalence of neonatal jaundice, Technological advancements, Expanding neonatal care access

Opportunities Home-based phototherapy, Growth in emerging economies

FAQs:

1. What is the current market size of the Global Infant Phototherapy Devices Market?

The market was valued at USD 432 million in 2023.

2. What is the major growth driver of the Global Infant Phototherapy Devices Market?

The primary driver is the rising prevalence of neonatal jaundice and increasing adoption of advanced phototherapy devices.

3. Which is the largest region during the forecast period in the Global Infant Phototherapy Devices Market?

North America currently leads, but Asia-Pacific is expected to grow the fastest during the forecast period.

4. Which segment accounted for the largest market share in the Global Infant Phototherapy Devices Market?

The LED Phototherapy Devices segment accounted for the largest share in 2023.

5. Who are the key market players in the Global Infant Phototherapy Devices Market?

Major players include GE Healthcare, Natus Medical, Philips Healthcare, and Drägerwerk AG.

Would you like a PDF version of this report description?